↓ Skip to main content

Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes

Overview of attention for article published in Canadian Medical Association Journal, July 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
52 news outlets
blogs
5 blogs
policy
2 policy sources
twitter
147 X users
facebook
9 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
88 Dimensions

Readers on

mendeley
161 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes
Published in
Canadian Medical Association Journal, July 2016
DOI 10.1503/cmaj.151059
Pubmed ID
Authors

Eszter P. Vamos, Utz J. Pape, Vasa Curcin, Matthew J. Harris, Jonathan Valabhji, Azeem Majeed, Christopher Millett

Abstract

The health burden caused by seasonal influenza is substantial. We sought to examine the effectiveness of influenza vaccination against admission to hospital for acute cardiovascular and respiratory conditions and all-cause death in people with type 2 diabetes. We conducted a retrospective cohort study using primary and secondary care data from the Clinical Practice Research Datalink in England, over a 7-year period between 2003/04 and 2009/10. We enrolled 124 503 adults with type 2 diabetes. Outcome measures included admission to hospital for acute myocardial infarction (MI), stroke, heart failure or pneumonia/influenza, and death. We fitted Poisson regression models for influenza and off-season periods to estimate incidence rate ratios (IRR) for cohorts who had and had not received the vaccine. We used estimates for the summer, when influenza activity is low, to adjust for residual confounding. Study participants contributed to 623 591 person-years of observation during the 7-year study period. Vaccine recipients were older and had more comorbid conditions compared with nonrecipients. After we adjusted for covariates and residual confounding, vaccination was associated with significantly lower admission rates for stroke (IRR 0.70, 95% confidence interval [CI] 0.53-0.91), heart failure (IRR 0.78, 95% CI 0.65-0.92) and pneumonia or influenza (IRR 0.85, 95% CI 0.74-0.99), as well as all-cause death (IRR 0.76, 95% CI 0.65-0.83), and a nonsignificant change for acute MI (IRR 0.81, 95% CI 0.62-1.04) during the influenza seasons. In this cohort of patients with type 2 diabetes, influenza vaccination was associated with reductions in rates of admission to hospital for specific cardiovascular events. Efforts should be focused on improvements in vaccine uptake in this important target group as part of comprehensive secondary prevention.

X Demographics

X Demographics

The data shown below were collected from the profiles of 147 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Unknown 160 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 26 16%
Student > Master 16 10%
Other 13 8%
Student > Bachelor 13 8%
Student > Ph. D. Student 12 7%
Other 33 20%
Unknown 48 30%
Readers by discipline Count As %
Medicine and Dentistry 61 38%
Nursing and Health Professions 11 7%
Biochemistry, Genetics and Molecular Biology 6 4%
Economics, Econometrics and Finance 4 2%
Agricultural and Biological Sciences 3 2%
Other 17 11%
Unknown 59 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 503. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2022.
All research outputs
#52,266
of 25,743,152 outputs
Outputs from Canadian Medical Association Journal
#97
of 9,541 outputs
Outputs of similar age
#1,047
of 381,394 outputs
Outputs of similar age from Canadian Medical Association Journal
#2
of 102 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,541 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,394 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.